Ledger.Open graph →

SEC Form D · filed April 1, 2021

IMPEL NEUROPHARMA INC

Offering

$1.9M

Sold

—

Exemption

Rule 506(b)

Industry

Other Health Care

Location

SEATTLE, WA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (33)

Stewart D. Parker · Seattle, WADirector Robert D. Mittendorff · Seattle, WADirector Aaron D. Royston · Seattle, WADirector John D. Leaman · Seattle, WAExec David D. Allison · Seattle, WADirector Tim D. Nelson · Seattle, WADirector Diane D. Wilfong · Seattle, WADirector John D. Hoekman · Seattle, WAExec · Director Mahendra D. Shah · Seattle, WADirector Ali D. Satvat · Seattle, WADirector Adrian D. Adams · Seattle, WAExec · Director Alexis Bjorlin · Sunnyvale, CAExec Michael Ettling · Miami, FLDirector William Toms · SAN FRANCISCO, CAExec · Director Jack Oslan · Pleasanton, CAExec · Director David Lazovsky · Sunnyvale, CADirector Anthony B. Davis · Chicago, ILDirector Brian B. Miller · Chicago, ILDirector Thomas Ritter · Chicago, ILDirector Reed Sturtevant · Sunnyvale, CADirector Andrew Parker · Chicago, ILDirector Jocelyn White · London, United KingdomDirector Raphael Schorr · Boston, MADirector Michael Coe · Perry, KSDirector Jay Po · LINCOLN, MADirector Karim Faris · Boston, MADirector Megan A. Bailey · Baltimore, MDDirector Stephan Cubba · Detroit, MIExec · Director Ping Wang · MOUNTAIN VIEW, CADirector Rick Mcdonald · Miami Lakes, FLExec · Director Glen Littlejohn · Miami Lakes, FLDirector Brian Fitzpatrick · Miami Lakes, FLExec Johnson Agogbua · Reston, VADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗